drugset / Trial / NCT01054989

Fat, Inflammation and Insulin Resistance

NCT01054989

Phase 4 Completed 16 enrolled German Diabetes Center
RandomizedCrossoverOpen-labelBasic science

Summary

The combination of impaired insulin sensitivity and insulin secretion is thought to be the basis of type 2 diabetes. Increased free fatty acids levels impair insulin action in muscle and liver, but also systemic inflammation processes play a role in the development of insulin resistance. This study compares the effects of fat and inflammation on insulin sensitivity, systemic inflammation, energy metabolism, vascular system and neural function in healthy humans.

Timeline

Start
2009-03-15
Primary completion
2011-09-15
Completion
2012-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glycerol Small molecule Intravenous
Comparator Intralipid Other / unclassified Intravenous
Comparator Lipopolysaccharide Other / unclassified Intravenous
Comparator Soybean Oil Unknown Oral

Indications

No indication recorded.